The pharmaceutical firm has followed several companies which have dropped diversity goals amid pressure from President Donald ...

President Donald Trump has issued a series of executive ... proposed increasing the annual salary of its Chief Executive Emma Walmsley to as much as 21.6 million pounds , from 10.6 million pounds ...

Drugmakers and analysts fear retaliation from Brussels will only exacerbate Europe’s drug supply issues. After raising ...

Dame Emma Walmsley prides herself on her tenacity ... business in 12 years - Christopher Dilts/Bloomberg This month, Donald Trump floated the idea of slapping 25pc tariffs on pharmaceutical ...

PhRMA CEO Steve Ubl took to the stage at The Anthem to carefully walk the line between supporting the Trump administration ... Meanwhile, GSK CEO Emma Walmsley told Lauren on the sidelines of ...

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's opposition to ...